BridgeBio Pharma

BBIO

Market cap $10.5B

Overview Fund Trends Analyst Outlook Journalist POV

Buy

Hold

Sell

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$72

30% upside

High target

7 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
HC Wainwright & Co Raghuram Selvaraju 78% 1-yr BBIO win rate				15 Sep ‘25 1 month ago
UBS Eliana Merle 100% 1-yr BBIO win rate				12 Sep ‘25 1 month ago
JP Morgan Anupam Rama 100% 1-yr BBIO win rate				3 Sep ‘25 1 month ago
Scotiabank Greg Harrison 67% 1-yr BBIO win rate				6 Aug ‘25 2 months ago
Oppenheimer Leland Gershell 100% 1-yr BBIO win rate				6 Aug ‘25 2 months ago
Cantor Fitzgerald Josh Schimmer 100% 1-yr BBIO win rate				29 Jul ‘25 2 months ago
Truist Securities Danielle Brill 100% 1-yr BBIO win rate				21 Jul ‘25 2 months ago